跳至主要内容
临床试验/NL-OMON52418
NL-OMON52418招募中3 期

Open-label randomized controlled trial for the effects of continuous ethinylestradiol/levonorgestrel (30/150 µg/day) compared with vitamin E (400 IU/day) in the treatment of menstrually-related migraine and migraine during perimenopause - WHAT! - RCT

eids Universitair Medisch Centrum0 个研究点目标入组 360 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
360

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • - menstrually-related migraine OR migraine in the early menopausal transition
  • - age >= 18
  • - demonstrated at least 80% compliance with eDiary during baseline period
  • - no or stable for at least two months on prophylactic medication

排除标准

  • - Migraine with aura
  • - Chronic migraine with 15 or more headache days per month/with 8 or more
  • migraine days per month
  • - Medication-overuse headache (ICHD-3 criteria)
  • - Women who are breastfeeding, pregnant, or planning to become pregnant
  • - Oral contraceptive use and not willing to undergo washout period (stop for
  • two consecutive months)
  • - Vitamin E use at start of the study
  • - Use of other sex hormone containing treatments
  • - Increased risk of VTE: history of VTE or thrombophlebitis, hereditary
  • predisposition for VTE (APC resistance, protein C or S deficiency, antithrombin
  • deficiency), VTE in first-degree family member with young age, long term
  • immobilisation
  • - Increased risk of ATE: history of ATE, hereditary predisposition for ATE
  • (hyperhomocysteinemia, antiphospholipid antibodies), ATE in first-degree family
  • member with young age, diabetes mellitus, total cholesterol >= 6.5
  • - Other contraindication for oral contraceptives: liver malignancy,
  • schistosomiasis, HIV/aids, use of immunosuppressives, tuberculosis,
  • sex-hormone-dependent malignancies (breast, endometrial or ovary carcinomas),
  • pancreatitis, vaginal bleeding with unknown cause, other diseases that can
  • influence vessels (malignancies, heart valve disorders, atrial fibrillation,
  • SLE, haemolytic uremic syndrome, chronic inflammatory bowel disease, sickle
  • cell disease)
  • - Contraindication for vitamin E: vitamin K deficiency
  • - Hypersensitivity for any of the compounds in oral contraceptive or vitamin E
  • - Spontaneous postmenopausal status (menstrual bleedings have ceased for 12
  • consecutive months)
  • - Iatrogenic postmenopausal status
  • - Inability to complete the electronic diary in an accurate manner
  • - Any serious illness that can compromise study participation

研究者

相似试验